CC BY-NC-ND 4.0 · J Neurol Surg Rep 2024; 85(03): e132-e137
DOI: 10.1055/a-2372-6701
Original Report

Posterior Fossa Ependymoma in a Child with Extensive Chondro-Osseous Metaplasia Occurring at Cerebellopontine Angle and Masquerading as a Vestibular Schwannoma: An Exceptionally Rare Clinicopathological Manifestation with Review of Literature

1   Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
Siddhartha Sankar Samanta
1   Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
1   Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
› Institutsangaben

Abstract

Ependymoma occurring at the cerebellopontine (CP) angle is an extremely uncommon sight and poses diagnostic and management dilemmas to neurosurgeons, radiologists, and neuropathologists alike. Moreover, the presence of extensive chondro-osseous metaplastic elements in ependymomas is an exceptionally infrequent histopathological manifestation. However, due to the seldom-seen nature of this histomorphological feature, there is no definite consensus regarding its etiopathogenesis and clinical consequences, and there is an extreme scarcity of literature elucidating its clinicopathological spectrum and prognostic significance. Herein, we illustrate an intriguing clinical tale of a 7-year-old male child with posterior fossa ependymoma, central nervous system (CNS) World Health Organization (WHO) grade 3, arising at the right CP angle and masquerading as a vestibular schwannoma, which in itself is a rare presentation, and additionally, exhibiting extensive chondro-osseous metaplasia, which is a very uncommon histomorphological observation. To the best of the authors' knowledge and after a comprehensive literature search, the coexistence of these two rare observations has merely been described once in international literature. This case sheds light on and highlights the importance of keeping ependymoma as a possible differential while coming across CP angle space-occupying lesions. They should be diligently distinguished from schwannomas and other masqueraders that typically occur at this site, as they have diverse management and follow-up protocols, with varying prognostic outcomes for the patients. Moreover, this case also unravels and details the clinicopathological characteristics of a scarcely described feature of chondro-osseous metaplasia in ependymomas.

Statement of Ethics

Written informed consent was taken from the patient's guardian to participate in this study and for the publication of any potentially identifiable images or data included in this article. Ethical review and approval are not required and are provided a waiver for the publication of case reports as per institutional requirements.


Authors' Contribution

S.M. had a key role in the conceptualization, drafting, and revision of the manuscript and the collection, analysis, and interpretation of the data. S.S.S. had a major contribution to curation, analysis, interpretation of data, and drafting of the manuscript. S.K. had an important role in diagnosing the case, conceptualization, providing resources, and critically revising the manuscript for important intellectual content.




Publikationsverlauf

Eingereicht: 05. Mai 2024

Angenommen: 17. Juni 2024

Accepted Manuscript online:
24. Juli 2024

Artikel online veröffentlicht:
29. August 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Rudà R, Bruno F, Pellerino A, Soffietti R. Ependymoma: evaluation and management updates. Curr Oncol Rep 2022; 24 (08) 985-993
  • 2 Louis DN, Perry A, Wesseling P. et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-oncol 2021; 23 (08) 1231-1251
  • 3 Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro-oncol 2020; 22 (12, Suppl 2): iv1-iv96
  • 4 Giridhar P, Nambirajan A, Benson R. Ependymoma. In: Mallick S, Giridhar P, Rath GK. eds. Evidence Based Practice in Neuro-Oncology. Singapore: Springer; 2021
  • 5 McGuire CS, Sainani KL, Fisher PG. Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg 2009; 110 (04) 725-729
  • 6 WHO Classification of Tumours Editorial Board. World Health Organization Classification of Tumours of the Central Nervous System. 5th ed.. Lyon: International Agency for Research on Cancer; 2021
  • 7 Salunke P, Sharma M, Gupta K, Kovai P, Aggarwal A. Cerebellopontine angle ependymoma in a 2-year- old child. J Neurosci Rural Pract 2012; 3 (02) 200-203
  • 8 Lan Z, Richard SA, Zhang Y. Cerebellopontine angle ependymoma in a young adult: A case report. Medicine (Baltimore) 2019; 98 (14) e15019
  • 9 Ebrahimi H, Jelodar S, Karimi Yarandi K, Eftekhar Javadi A, Alimohamadi M. Adult cerebellopontine angle ependymoma presenting as an isolated cisternal mass: a case report. J Med Imaging Radiat Sci 2020; 51 (04) 689-693
  • 10 Dibs K, Prasad RN, Madan K. et al. Cerebellopontine angle ependymoma presenting as isolated hearing loss in an elderly patient: a case report and literature review. Surg Neurol Int 2021; 12: 572
  • 11 Chakraborti S, Govindan A, Alapatt JP, Radhakrishnan M, Santosh V. Primary myxopapillary ependymoma of the fourth ventricle with cartilaginous metaplasia: a case report and review of the literature. Brain Tumor Pathol 2012; 29 (01) 25-30
  • 12 Kepes JJ, Rubinstein LJ, Chiang H. The role of astrocytes in the formation of cartilage in gliomas. An immunohistochemical study of four cases. Am J Pathol 1984; 117 (03) 471-483
  • 13 Wang X, Zhang S, Ye Y, Chen Y, Liu X. Ependymoma with cartilaginous metaplasia might have more aggressive behavior: a case report and literature review. Brain Tumor Pathol 2012; 29 (03) 172-176
  • 14 Bannykh S, Baehring JM. Images in neuro-oncology: rapid development of osseous and chondrous metaplasia in recurrent anaplastic ependymoma. J Neurooncol 2007; 81 (03) 257-258
  • 15 Mridha AR, Sharma MC, Sarkar C, Garg A, Singh MM, Suri V. Anaplastic ependymoma with cartilaginous and osseous metaplasia: report of a rare case and review of literature. J Neurooncol 2007; 82 (01) 75-80
  • 16 Gessi M, Kuchelmeister K, Lauriola L, Pietsch T. Rare histological variants in ependymomas: histopathological analysis of 13 cases. Virchows Arch 2011; 459 (04) 423-429
  • 17 Alkhaibary A, AlSufiani F, Alassiri AH, Almuntashri M, Al Qutub ST. Chondro-osseous metaplasia in ependymoma: a rare histopathological finding. Case Rep Pathol 2020; 2020: 1528698
  • 18 Rudà R, Reifenberger G, Frappaz D. et al. EANO guidelines for the diagnosis and treatment of ependymal tumors. Neuro-oncol 2018; 20 (04) 445-456
  • 19 Neyazi S, Yamazawa E, Hack K. et al. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation. Acta Neuropathol 2024; 147 (01) 22